FLT3-ITD Inhibitor Improves Survival in Relapsed AML

(MedPage Today) -- More quizartinib-treated patients went on to stem cell transplant

Source: MedPage Today Hematology/Oncology - June 20, 2018 Category: Hematology Source Type: news